Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 388.25
-21.90 (-5.34%)
At close: Dec 4, 2025
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
10.10M INR
Profits / Employee
297.58K INR
Market Cap
523.98B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | 12,609 | 1,266 | 11.16% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Biocon News
- 4 days ago - Biocon Biologics secures market pathway for Denosumab Biosimilars in Europe following settlement with Amgen - Business Upturn
- 11 days ago - Going bananas for Bengaluru’s road safety: Kiran Mazumdar-Shaw’s compliment sparks buzz on X - The Times of India
- 16 days ago - Biocon shares fall sharply over 3% as Citi downgrades stock to ‘Sell’ with target price to Rs 360 - Business Upturn
- 17 days ago - Biocon subsidiary gets U.S. FDA approval for Tofacitinib Extended-Release tablets - Business Upturn
- 22 days ago - Biocon clarifies on merger speculation, says committee still evaluating restructuring options - Business Upturn
- 22 days ago - US Proposal Could Halve Biocon's Biosimilar Development Costs - NDTV
- 23 days ago - Biocon shares surge over 3% today on strong Q2 performance: Should you buy the stock? — explained - Business Upturn
- 23 days ago - Biocon MD says board has not taken any action on Biocon Biologics merger yet: Report - Business Upturn